CAC
AKBA icon

Certified Advisory Corp’s Akebia Therapeutics AKBA Stock Holding History

Certified Advisory Corp’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-168
Closed -$1K – 787
2019
Q3 		$1K Hold
168
– – ﹤0.01% 760
2019
Q2 		$1K Hold
168
– – ﹤0.01% 767
2019
Q1 		$1K Hold
168
– – ﹤0.01% 709
2018
Q4 		$1K Buy
+168
New +$1.31K ﹤0.01% 702

Other funds holding AKBA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Certified Advisory Corp's AKBA Position: Q4 2019 in Review

Certified Advisory Corp sold out of Akebia Therapeutics (AKBA) in Q4 2019, closing a stake of 168 shares — an estimated $1K sold.

Certified Advisory Corp first reported a position in AKBA in Q4 2018 and held it in 4 quarters. The position peaked at $1K in Q3 2019. 153 funds tracked by Wall St. Rank hold AKBA as of Q4 2019.

  • Certified Advisory Corp reported no remaining Akebia Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Certified Advisory Corp sold 168 Akebia Therapeutics shares in Q4 2019, an estimated $1K.
  • Certified Advisory Corp first reported a position in Akebia Therapeutics in Q4 2018 and held it in 4 quarters.
  • Certified Advisory Corp's Akebia Therapeutics position peaked at $1K in Q3 2019.
  • 153 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2019.

Based on Certified Advisory Corp's 13F filing for Q4 2019, filed 29 Jan 2020.